Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare.

Existing micronutrient deficiencies, even if only a single micronutrient, can impair immune function and increase susceptibility to infectious disease. Certain population groups are more likely to have micronutrient deficiencies, while certain disease pathologies and treatment practices also exacerbate risk, meaning these groups tend to suffer increased morbidity and mortality from infectious diseases. Optimisation of overall nutritional status, including micronutrients, can be effective in reducing incidence of infectious disease. Micronutrient deficiencies are rarely recognised but are prevalent in the UK, as well as much more widely, particularly in high-risk groups susceptible to COVID-19. Practitioners should be aware of this fact and should make it a consideration for the screening process in COVID-19, or when screening may be difficult or impractical, to ensure blanket treatment as per the best practice guidelines. Correction of established micronutrient deficiencies, or in some cases assumed suboptimal status, has the potential to help support immune function and mitigate risk of infection. The effects of and immune response to COVID-19 share common characteristics with more well-characterised severe acute respiratory infections. Correction of micronutrient deficiencies has proven effective in several infectious diseases and has been shown to promote favourable clinical outcomes. Micronutrients appear to play key roles in mediating the inflammatory response and such effects may be enhanced through correction of deficiencies. Many of those at highest risk during the COVID-19 pandemic are also populations at highest risk of micronutrient deficiencies and poorer overall nutrition. Correction of micronutrient deficiencies in established COVID-19 infection may contribute to supporting immune response to infection in those at highest risk. There is a need for further research to establish optimal public health practice and clinical intervention regimens.

Experimental leaching of massive sulphide from TAG active hydrothermal mound and implications for seafloor mining.

Seafloor massive sulphide samples from the Trans-Atlantic Geotraverse active mound on the Mid-Atlantic Ridge were characterised and subjected to leaching experiments to emulate proposed mining processes. Over time, leached Fe is removed from solution by the precipitation of Fe oxy-hydroxides, whereas Cu and Pb leached remained in solution at ppb levels. Results suggest that bulk chemistry is not the main control on leachate concentrations; instead mineralogy and/or galvanic couples between minerals are the driving forces behind the type and concentration of metals that remain in solution. Dissolved concentrations exceed ANZECC toxicity guidelines by 620 times, implying the formation of localised toxicity in a stagnant water column. Moreover, concentrations will be higher when scaled to higher rock-fluid ratios and finer grain sizes proposed for mining scenarios. The distance at which dilution is achieved to meet guidelines is unlikely to be sufficient, indicating a need for the refinement of the mining process.